Skip to main content

News Library

AD
News
04/10/2025
Riya Gandhi, MA
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab...
04/10/2025
APP Institute Dermatology
telemedicine
News
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
APP Institute Dermatology
contact dermtitis + Neck + Eczema + rash
News
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
APP Institute Dermatology
SOC
News
01/29/2025
Riya Gandhi, MA
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of...
01/29/2025
APP Institute Dermatology
Atopic dermatitis
News
01/17/2025
Riya Gandhi, MA
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Atopic dermatitis
News
01/07/2025
Riya Gandhi, MA
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology